Changes in calpain-2 expression during glioblastoma progression predisposes tumor cells to temozolomide resistance by minimizing DNA damage and p53-dependent apoptosis

Maren Nicole Stillger(University of Freiburg), Oliver Schilling(Infineon Technologies (Germany))
bioRxiv (Cold Spring Harbor Laboratory)
October 20, 2022
Cited by 0


Related Papers